Published in Obesity and Diabetes Week, December 26th, 2005
The SemBioSys research team will publish the results in Plant Biotechnology Journal in an article titled "Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds." The study demonstrates bio-equivalence of purified insulin from Arabidopsis seeds when compared with commercial insulin products in an animal model.
The article details...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.